Agenus (Formerly known as Antigenics Inc. - New York)

108 articles about Agenus (Formerly known as Antigenics Inc. - New York)

• Antigenics Inc. (New York) Sells $25 Million Of Convertible Senior Secured Notes

  10/31/2006

• Antigenics Inc. (New York) Reports Third Quarter 2006 Financial Results

  10/31/2006

• Antigenics Inc. (New York) To Report Third Quarter 2006 Financial Results On October 31, 2006; Conference Call To Follow

  10/24/2006

• Hyam I. Levitsky, MD, Joins Antigenics Inc. (New York)'s Board Of Directors

  9/14/2006

• Antigenics Inc. (New York) CEO To Present At Bear Stearns 19th Annual Healthcare Conference

  9/5/2006

• Antigenics Inc. (New York) Reports Second Quarter 2006 Financial Results

  8/1/2006

• Antigenics Inc. (New York) To Report Second Quarter 2006 Financial Results On August 1, 2006

  7/25/2006

• Antigenics Inc. (New York) Says CFO To Leave, Names Replacement

  7/24/2006

• Antigenics Inc. (New York) Announces Expansion Of Its License And Supply Agreement With GlaxoSmithKline Biologicals For QS-21 Stimulon(R) Adjuvant

  7/10/2006

• Antigenics Inc. (New York) Announces Results From In-Depth Analysis Of Phase 3 Data Of Oncophage In Kidney Cancer And Provides Regulatory Update

  6/7/2006

• Antigenics Inc. (New York) Presents Phase 3 Data Trom Trial Of Oncophage In Metastatic Melanoma At ASCO Meeting; Cancer Vaccine Misses Study Goal

  6/5/2006

• Antigenics Inc. (Lexington, MA) To Webcast 2006 Annual Shareholders Meeting

  6/2/2006

• Antigenics Inc. (New York) Reports First Quarter 2006 Financial Results

  5/3/2006

• Antigenics Inc. (New York) To Report First Quarter 2006 Financial Results On May 3, 2006

  4/25/2006

• Antigenics Inc. (New York) Reports Phase 3 Results For Oncophage In Kidney Cancer; Study Did Not Meet Endpoints; Stock Plunges

  3/24/2006

• Antigenics Inc. (New York) CEO To Present At SG Cowen & Co., LLC's 26th Annual Health Care Conference

  2/28/2006

• Antigenics Inc. (New York) Reports Fourth Quarter And Year-End 2005 Financial Results And Highlights

  2/23/2006

• Antigenics Inc. (New York) To Report Fourth Quarter And Year-End 2005 Financial Results On February 23, 2006

  2/16/2006

• Antigenics Inc. (New York) CEO To Present At JPMorgan's 24th Annual Healthcare Conference

  1/5/2006

• Bruce A. Leicher Joins Antigenics Inc. (New York) As General Counsel

  12/13/2005